 | |
| Clinical data | |
|---|---|
| Trade names | Lenen, Novoderm, Varlane, Vaspit |
| Other names | FCB; SHK-203; Fluocortin 21-butylate; Fluocortin butylate; Fluocortolone-21-carboxylate 21-butyl; 6α-Fluoro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-oic acid butyl ester |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.050.476  |
| Chemical and physical data | |
| Formula | C26H35FO5 |
| Molar mass | 446.559 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Fluocortin butyl (brand names Lenen, Novoderm, Varlane, Vaspit), or fluocortin 21-butylate, is a synthetic glucocorticoid corticosteroid which is marketed in Germany, Belgium, Luxembourg, Spain, and Italy. Chemically, it is the butyl ester derivative of fluocortin.
It was patented in 1971 and approved for medical use in 1977.
References
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 563–. ISBN 978-1-4757-2085-3.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 457–. ISBN 978-3-88763-075-1.
- Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 487. ISBN 9783527607495.
| Glucocorticoids and antiglucocorticoids (D07, H02) | |
|---|---|
| Glucocorticoids | |
| Antiglucocorticoids |
|
| Synthesis modifiers | |
| |
 | This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |